BioSpace News Archive

Drug Development

ASCO2016: ARMO BioSciences AM0010 Demonstrates Promising Clinical Data As An Immuno-Oncology Monotherapy And In Combination With An Anti-PD-1 Checkpoint Inhibitor In Advanced Solid Tumors, Including Immune-Resistant Cancers

June 6, 2016
·
6 min read
Drug Development

Three Signature Projects at Google’s Verily Plagued by Serious, If Not Fatal, Scientific Shortcomings

June 6, 2016
·
1 min read
Drug Development

ASCO2016: Exelixis And Its Partner Ipsen Announce Positive Overall Survival Results From Subgroup Analyses Of Phase III Trial Of CABOMETYX (Cabozantinib) Tablets In Advanced Renal Cell Carcinoma At 2016 ASCO Annual Meeting

June 6, 2016
·
11 min read
Business

Mass Innovation Labs Adds “Innovation Suites” to Kendall Square Facility

June 6, 2016
·
2 min read
Drug Development

ASCO2016: Merck & Co. And Pfizer Release: Pivotal Avelumab Study Shows Positive Results In Metastatic Merkel Cell Carcinoma

June 6, 2016
·
10 min read
Job Trends

Quest Diagnostics to Relocate Corporate HQ and Consolidate Office Facilities, in New Jersey

June 6, 2016
·
2 min read
Job Trends

Boston Biotech Execs Job-Hopping Due to Scientific Breakthroughs, Startups Rolling in Cash and Big Pharma Setting Up Shop

June 6, 2016
·
1 min read
BioMidwest

ASCO2016: Guardant Health’s ‘Liquid’ Cancer Test Offers Hope for Alternative to Painful Biopsies

June 6, 2016
·
3 min read
Business

ArcherDX Partners With Illumina To Bring Leading Fusion Oncology Assays To Global Markets

June 6, 2016
·
1 min read
Drug Development

ASCO2016: Kolltan Pharmaceuticals Inc. Presents Clinical Data For KTN3379 In An Oral Presentation At The 2016 American Society of Clinical Oncology (ASCO) Annual Meeting

June 6, 2016
·
8 min read